Pfizer Beats Expectations in Q3 and Raises Its Guidance. Is the Stock Due for a Big Rally?
The healthcare stock may finally have the catalyst that it needs to take off before the end of the year.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.